Literature DB >> 34330020

Rates, Predictors, and Impact of Smoking Cessation after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis.

Jean Jacques Noubiap1, John L Fitzgerald2, Celine Gallagher3, Gijo Thomas4, Melissa E Middeldorp5, Prashanthan Sanders6.   

Abstract

BACKGROUND: Smoking cessation after a first cardiovascular event reduces the risk of recurrent vascular events and mortality. This systematic review and meta-analysis aimed to summarize data on the rates, predictors, and the impact of smoking cessation in patients after a stroke or transient ischemic attack (TIA).
METHODS: MEDLINE, EMBASE and Web of Science were searched to identify all published studies providing relevant data through May 20, 2021. Random-effects meta-analysis method was used to pool proportions. Some findings were summarized narratively.
RESULTS: Twenty-five studies were included. The pooled smoking cessation rates were 51.0% (8 studies, n = 1738) at 3 months, 44.4% (7 studies, n = 1920) at 6 months, 43.7% (12 studies, n = 1604) at 12 months, and 49.8% (8 studies, n = 2549) at 24 months or more of follow-up. Increased disability and intensive smoking cessation support programs were associated with a higher likelihood of smoking cessation, whereas alcohol consumption and depression had an inverse effect. Two studies showed that patients who quit smoking after a stroke or a TIA had substantially lower risk of recurrent stroke, death, and a composite of stroke, myocardial infarction, and death.
CONCLUSION: Smoking cessation in stroke survivors is associated with reduced recurrent vascular events and death. About half of smokers who experience a stroke or a TIA stop smoking afterwards. Those with low post-stroke disability, who consume alcohol, or have depression are less likely to quit. Intensive support programs can increase the likelihood of smoking cessation.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Stroke; cessation; smoking; tobacco

Year:  2021        PMID: 34330020     DOI: 10.1016/j.jstrokecerebrovasdis.2021.106012

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  3 in total

1.  Juvenile patients with the homozygous MTHFR C677T genotype develop ischemic stroke 5 years earlier than wild type.

Authors:  Paul R J Ames; Giovanna D'Andrea; Vincenzo Marottoli; Alessia Arcaro; Luigi Iannaccone; Fabrizio Gentile; Maurizio Maraglione
Journal:  J Thromb Thrombolysis       Date:  2022-08-02       Impact factor: 5.221

2.  Prescription smoking-cessation medication pharmacy claims after stroke and transient ischemic attack.

Authors:  Neal S Parikh; Yongkang Zhang; Daniel Restifo; Erika Abramson; Matthew J Carpenter; Babak B Navi; Hooman Kamel
Journal:  Prev Med Rep       Date:  2021-12-28

Review 3.  Harmful Impact of Tobacco Smoking and Alcohol Consumption on the Atrial Myocardium.

Authors:  Amelie H Ohlrogge; Lars Frost; Renate B Schnabel
Journal:  Cells       Date:  2022-08-18       Impact factor: 7.666

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.